We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Off-Pump Bypass Safe for High-Risk Patients

By HospiMedica staff writers
Posted on 27 Oct 2004
Patients at high risk for complications after heart surgery may benefit from off-pump surgery, according to a study reported at the annual Clinical Congress of the American College of Surgeons (ACS) in New Orleans (LA, USA) in October 2004.

The standard on-pump procedure, which allows surgeons to operate on the heart at rest while blood pumps through a heart-lung machine, generates a systemic inflammatory response because the patient's blood comes in contact with artificial surfaces. More...
This may cause lung insufficiency, bleeding, kidney insufficiency, or stroke in high-risk patients. The on-pump procedure also minimizes pulsatile blood flow. The absence of normal heart movement is correlated with a high incidence of renal failure in patients with renal insufficiency. In addition, because the on-pump operation requires the aorta to be clamped, it can further compromise a calcified aorta.

Since 2000, Dr. John C. Chen, M.D., and his surgical team have performed 191 off-pump artery bypass operations on high-risk patients. For 97 patients who underwent the procedure in 2002, the expected mortality was 7.68%, but the observed mortality was only 4.17%. In 2003, the outcome was even better. The expected mortality for 54 patients in off-pump procedures was 7.85%, while the observed mortality was only 1.85%.

Among new tools that have improved the surgery is an apical suction device placed on the apex of the heart to hold it steady during surgery and a new stabilizing device that is placed on the coronary artery to hold it relatively steady. "The artery is not completely still, but it is still enough so experienced surgeons can do an anastomosis with good results,” reported Dr. Chen, who is a professor at the University of Hawaii and chief of cardiothoracic surgery at Kaiser Permanente, Honolulu (Hawaii, USA). Dr. Chen reported the study's findings.


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.